{"title": "Cheng MP, Pandit A, Antin JH, et al. Safety and immunogenicity of conjugate quadrivalent meningococcal vaccination after hematopoietic cell transplantation. Blood Adv. 2018;2(11):1272-1276.", "author": null, "url": "https://dx.doi.org/10.1182/bloodadvances.2018022376", "hostname": "doi.org", "description": "In the first paragraph of \"Methods\" on page 1273 in the 12 June 2018 issue, the manufacturer of the meningococcal vaccine Menactra was listed as GlaxoSmithKline", "sitename": "American Society of Hematology", "date": "2018-07-10", "cleaned_text": "In the first paragraph of \"Methods\" on page 1273 in the 12 June 2018 issue, the manufacturer of the meningococcal vaccine Menactra was listed as GlaxoSmithKline, Philadelphia, PA. It is actually Sanofi Pasteur Inc, Swiftwater, PA. The error has been corrected in the published article. \u00a9 2018 by The American Society of Hematology 2018 "}